Abstract:Sarcomas are rare, heterogeneous mesenchymal neoplasms with various subtypes, each exhibiting unique genetic characteristics. Although studies have been conducted to improve the treatment for sarcomas, the specific development from normal somatic cells to sarcoma cells is still unclear and needs further research. The diagnosis of sarcomas depends heavily on the pathological examination, which is yet a difficult work and requires expert analysis. Advanced treatment like precise medicine optimizes the efficacy of treatment and the prognosis of sarcoma patients, yet, in sarcomas, more studies should be done to put such methods in clinical practice. The revolution of advanced technology has pushed the multi-omics approach to the front, and more could be learnt in sarcomas with such methods. Multi-omics combines the character of each omics techniques, analyzes the mechanism of tumor cells from different levels, which makes up for the shortage of single-omics, and gives us an integrated picture of bioactivities inside tumor cells. Multi-omics research of sarcomas has reached appreciable progress in recent years, leading to a better understanding of the mutation, proliferation, and metastasis of sarcomas. With the help of multi-omics approach, novel biomarkers were found, with promising effects in improving the process of diagnosis, prognosis anticipation, and treatment decision. By analyzing large amounts of biological features, subtype clustering could be done in a better precision, which may be useful in the clinical procedure. In this review, we summarized recent discoveries using multi-omics approach in sarcomas, discussed their merits and challenges, and concluded with future perspectives of the sarcoma research.

The Expressions and Mechanisms of Sarcomeric Proteins in Cancers

Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications

Proteasome dysregulation in human cancer: implications for clinical therapies

A narrative review of the roles of muscle segment homeobox transcription factor family in cancer

Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

The Curious Role of Sarcomeric Proteins in Control of Diverse Processes in Cardiac Myocytes

Telomeres and telomerase in Sarcoma disease and therapy

Transcriptional regulation and therapeutic potential of cyclin-dependent kinase 9 (CDK9) in sarcoma

Mesenchymal to epithelial transition in sarcomas.

The role of the CXCL12-CXCR4/CXCR7 axis in the progression and metastasis of bone sarcomas (Review).

The Role Of The Cxcl12-Cxcr4/Cxcr7 Axis In The Progression And Metastasis Of Bone Sarcomas

Exosomes in the tumor microenvironment of sarcoma: from biological functions to clinical applications

CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications

Application of Multi-Omics Approach in Sarcomas: A Tool for Studying Mechanism, Biomarkers, and Therapeutic Targets.

The molecular pathology of sarcomas

Mechanisms of tropomyosin 3 in the development of malignant tumors

Integrins in cancer: Emerging mechanisms and therapeutic opportunities

Regulation of cancer cell metabolism: oncogenic MYC in the driver’s seat

Targeting Myc Interacting Proteins As a Winding Path in Cancer Therapy

Role of oncogenic REGγ in cancer

Application of Biomechanics in Tumor Epigenetic Research